DrugPatentWatch Database Preview
VRAYLAR Drug Profile
see a sample report or, see our see our flat-rate plans
When do Vraylar patents expire, and what generic alternatives are available?
This drug has seventy-nine patent family members in thirty-six countries.
The generic ingredient in VRAYLAR is cariprazine hydrochloride. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the cariprazine hydrochloride profile page.
Summary for VRAYLAR
| International Patents: | 79 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 18 |
| Clinical Trials: | 2 |
| Patent Applications: | 18 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | VRAYLAR at DailyMed |
Generic Entry Opportunity Date for VRAYLAR
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for VRAYLAR
| Drug Class | Atypical Antipsychotic |
Synonyms for VRAYLAR
| 1083076-69-0 |
| 3-((1R,4r)-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-1,1-dimethylurea hydrochloride |
| AK341028 |
| AKOS027338713 |
| Cariprazine (hydrochloride) |
| Cariprazine HCl |
| CARIPRAZINE HYDROCHLORIDE |
| Cariprazine hydrochloride (JAN/USAN) |
| Cariprazine hydrochloride [USAN] |
| cariprazine monohydrochloride |
| cariprazine.HCl |
| CHEBI:90932 |
| CHEMBL2024517 |
| CS-1570 |
| D09876 |
| EX-A1644 |
| FT-0701196 |
| HY-14763A |
| KQD7C255YG |
| KS-00000640 |
| MFCD26142670 |
| MolPort-044-723-876 |
| N'-(Trans-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-N,N-dimthylurea monohydrochloride |
| N'-(trans-4-{2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl}cyclohexyl)-N,N-dimethylurea hydrochloride |
| RGH-188 HCL |
| SCHEMBL183803 |
| SCHEMBL183804 |
| UNII-KQD7C255YG |
| Urea, N'-(trans-4-(2-(4-(2,3-dichlorophenyl)-1-piperazinyl)ethyl)cyclohexyl)-N,N- dimethyl-, hydrochloride (1:1) |
| Vraylar (TN) |
US Patents and Regulatory Information for VRAYLAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan Sales Llc | VRAYLAR | cariprazine hydrochloride | CAPSULE;ORAL | 204370-001 | Sep 17, 2015 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Allergan Sales Llc | VRAYLAR | cariprazine hydrochloride | CAPSULE;ORAL | 204370-002 | Sep 17, 2015 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Allergan Sales Llc | VRAYLAR | cariprazine hydrochloride | CAPSULE;ORAL | 204370-001 | Sep 17, 2015 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Allergan Sales Llc | VRAYLAR | cariprazine hydrochloride | CAPSULE;ORAL | 204370-003 | Sep 17, 2015 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
International Patents for VRAYLAR
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Brazil | PI0413283 | ➤ Sign Up |
| Serbia | 20060041 | ➤ Sign Up |
| Ecuador | SP099772 | ➤ Sign Up |
| South Korea | 20150090264 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for VRAYLAR
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 0913 | Netherlands | ➤ Sign Up | PRODUCT NAME: CARIPRAZINE, OPTIONEEL IN DE VORM VAN EEN ZOUT, WAARONDER CARIPRAZINE HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/17/1209 20170717 |
| 2017 00042 | Denmark | ➤ Sign Up | PRODUCT NAME: CARIPRAZINE, OPTIONALLY IN THE FORM OF A SALT, INCLUDING THE CARIPRAZINE HYDROCHLORIDE; REG. NO/DATE: EU/1/17/1209 20170717 |
| /2017 | Austria | ➤ Sign Up | PRODUCT NAME: CARIPRAZIN, GEGEBENENFALLS IN FORM EINES SALZES, EINSCHLIESSLICH CARIPRAZIN HYDROCHLORID; REGISTRATION NO/DATE: EU/1/17/1209 (MITTEILUNG) 20170717 |
| 2017000083 | Germany | ➤ Sign Up | PRODUCT NAME: CARIPRAZIN, GEGEBENENFALLS IN FORM EINES SALZES, EINSCHLIESSLICH CARIPRAZINHYDROCHLORID; REGISTRATION NO/DATE: EU/1/17/1209 20170713 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
